Halt Aging in Survivors of Blood Cancers

Recruiting N/A Interventional Study
Hematological Malignancy Leukemia Lymphoid Leukemia Multiple Myeloma Myeloid Leukemia Monocytic Leukemia Non-hodgkin Lymphoma Other Hematologic Condition
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
180 (estimated)
Sponsor
University of Nebraska · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age ≥50 years 2. A history of hematological malignancy 3. Participants must be able to and willingly give informed consent Exclusion Criteria: 1. Patients receiving intensive induction or consolidation chemotherapy. Maintenance chemotherapy, or lower-intensity chemotherapy …
Contacts

Taylor Johnson

402-559-4596

taylora.johnson@unmc.edu

CONTACT

IIT OFFICE

402-559-4596

iitoffice@unmc.edu

CONTACT